Kratom Consumption - The Tales of Three Patients.

J Psychoactive Drugs

Psychiatry Department, Dartmouth's Geisel School of Medicine, Hanover, NH, USA.

Published: November 2024

The rising prevalence of kratom use in the United States has led to increased encounters with individuals who consume kratom and those who develop Kratom Use Disorder (KUD) among healthcare professionals. This case series highlights the need for diverse treatment approaches tailored to the individual motivations for kratom consumption. Three cases are presented: one involving the progression from kratom use for energy to opioid-driven use with subsequent challenges in detoxification and transition to naltrexone necessitating buprenorphine low-dose induction for maintenance; another detailing successful inpatient detoxification using methadone and symptom-driven clonidine, followed by successful maintenance treatment with naltrexone; and a final case involving kratom consumption for pain and anxiety self-management by an individual without a history of addictive disorders, without meeting KUD criteria. These cases underscore the complexity of managing individuals who consume kratom as well as those who develop dependence, emphasizing the need for individualized treatment approaches considering various factors such as motivation for use, psychiatric comorbidities, and response to interventions.

Download full-text PDF

Source
http://dx.doi.org/10.1080/02791072.2024.2424278DOI Listing

Publication Analysis

Top Keywords

kratom consumption
12
kratom
8
individuals consume
8
consume kratom
8
treatment approaches
8
consumption tales
4
tales three
4
three patients
4
patients rising
4
rising prevalence
4

Similar Publications

Mitragynine is an "atypic opioid" analgesic with an alternative mechanism of action and a favorable side-effect profile. Our aim was to optimize the alkaloid extraction procedure from kratom leaves and to determine and isolate the most relevant compounds capable of penetrating the central nervous system. The PAMPA-BBB study revealed that mitragynine and its coalkaloids, speciociliatine, speciogynine, and paynantheine, possess excellent in vitro BBB permeability.

View Article and Find Full Text PDF
Article Synopsis
  • A study explored the link between kratom use and aggression among male methamphetamine (METH) users, involving 403 participants and various clinical measures.
  • No significant differences in aggression levels were found between METH users and those with a history of kratom use, although two distinct clusters of users emerged based on their kratom consumption patterns.
  • In Cluster 1, higher kratom use correlated with increased aggression, while in Cluster 2, lower frequency of kratom use acted as a protective factor against aggression, suggesting that moderate kratom use may reduce aggression in some METH users.
View Article and Find Full Text PDF

The rising prevalence of kratom use in the United States has led to increased encounters with individuals who consume kratom and those who develop Kratom Use Disorder (KUD) among healthcare professionals. This case series highlights the need for diverse treatment approaches tailored to the individual motivations for kratom consumption. Three cases are presented: one involving the progression from kratom use for energy to opioid-driven use with subsequent challenges in detoxification and transition to naltrexone necessitating buprenorphine low-dose induction for maintenance; another detailing successful inpatient detoxification using methadone and symptom-driven clonidine, followed by successful maintenance treatment with naltrexone; and a final case involving kratom consumption for pain and anxiety self-management by an individual without a history of addictive disorders, without meeting KUD criteria.

View Article and Find Full Text PDF

Rare Case of Photodistributed Hyperpigmentation Linked to Kratom Consumption.

Cutis

September 2024

Isha Gandhi is from the University of Minnesota Medical School, Twin Cities Campus, Minneapolis. Dr. Wang is from the Laboratory of Dermatopathology, Woodbury, New York. Dr. Fishman is from the Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.

View Article and Find Full Text PDF

Mitragynine and morphine produce dose-dependent bimodal action on food but not water intake in rats.

Am J Physiol Regul Integr Comp Physiol

December 2024

Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida, United States.

Kratom (), containing the primary alkaloid mitragynine, has emerged as an alternative self-treatment for opioid use disorder. Mitragynine binds numerous receptor types, including opioid receptors, which are known to modulate food consumption. However, the ability of acute mitragynine to modulate food consumption remains unknown.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!